CD169-positive macrophages in lymph nodes and the tumor microenvironment: harnessing their biology for clinical diagnosis and anticancer therapeutic strategies - Takeaways - MDSpire

CD169-positive macrophages in lymph nodes and the tumor microenvironment: harnessing their biology for clinical diagnosis and anticancer therapeutic strategies

  • By

  • Ryo Fukuda

  • Yukio Fujiwara

  • Toru Maruyama

  • Yoshihiro Komohara

  • June 24, 2026

  • 0 min

Share

  • 1

    CD169+ macrophages are crucial in regulating immune responses in secondary lymphoid organs and various peripheral tissues.

  • 2

    In cancer, CD169+ macrophages in tumor-draining lymph nodes and the tumor microenvironment influence clinical outcomes.

  • 3

    The functional roles of CD169+ macrophages are context-dependent, varying by tissue niche, tumor type, and treatment.

  • 4

    High densities of CD169+ macrophages in tumor-draining lymph nodes correlate with improved overall and progression-free survival.

  • 5

    CD169+ macrophages are potential prognostic biomarkers and targets for immunotherapeutic strategies in cancer treatment.

Original Source(s)

CD169-positive macrophages in lymph nodes and the tumor microenvironment: harnessing their biology for clinical diagnosis and anticancer therapeutic strategies

  • by Ryo Fukuda, Yukio Fujiwara, Toru Maruyama, Yoshihiro Komohara

  • June 24, 2026

Related Content

Distribution analysis of gynecological carcinomas with concurrent second primary carcinomas

Severe asparaginase-associated hypertriglyceridemia in pediatric acute lymphoblastic leukemia: a single-center experience

Combined immunohistochemistry and FISH testing for diagnosing metaplastic thymoma: a case report of misdiagnosis as pulmonary mucinous epidermoid carcinoma